In addition, data from large cohort studies further support the diagnostic value of AKR1B10 as a potential HCC serum marker superior to conventional AFP, which may contribute to the early diagnosis and prognostic assessment of HCC (112). This evidence concerns the gene AFP and hepatocellular carcinoma.